Labs / ADME, DMPK & toxicology

Feldan Therapeutics
Quebec City, QC, Canada · feldan.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Feldan Therapeutics is a clinical-stage biotech company that develops treatments based on intracellular delivery of therapeutics. It is based in Quebec, Canada, and operates across clinical development in the United States and Australia through its wholly owned subsidiary Feldan Australia Pty Ltd.
They take quote requests by email.
What they offer
Intracellular delivery platform development
Develops the Feldan Shuttle® peptide-based technology for delivering therapeutics into cells and reaching intracellular targets.
ASO delivery development
Develops local delivery of antisense oligonucleotides to cells using the Feldan Shuttle® platform.
Clinical development of FLD-103
Conducts a Phase 1 clinical trial of FLD-103, an investigational non-surgical treatment for basal cell carcinoma.
Preclinical development of FLD-201
Advances FLD-201, an inhaled investigational therapy for mucus-driven respiratory diseases, in preclinical development.
What they work on
- Modalities
- Peptide, Oligonucleotide
- Species and models
- rhesus monkey airway epithelial cells, mouse airway epithelia, well-differentiated airway epithelial cells
- Therapeutic areas
- basal cell carcinoma, mucus-driven respiratory diseases, non-cystic fibrosis bronchiectasis, chronic bronchitis
- Sites
- Quebec, Canada · Quebec, Quebec, Canada
- Serves
- United States, Australia
- Address
- 2666 Boulevard du Parc Technologique, Suite 290 Quebec, Quebec, Canada, G1P 4S6
Similar labs. ACM Global Laboratories, Aurigene Pharmaceutical Services, BioDuro, HitGen
Found in a contract services directory. Listing built from feldan.com. Work here? Claim this listing.